全文获取类型
收费全文 | 2377386篇 |
免费 | 174155篇 |
国内免费 | 3446篇 |
专业分类
耳鼻咽喉 | 32339篇 |
儿科学 | 76797篇 |
妇产科学 | 63257篇 |
基础医学 | 352048篇 |
口腔科学 | 63984篇 |
临床医学 | 214750篇 |
内科学 | 463265篇 |
皮肤病学 | 52416篇 |
神经病学 | 188158篇 |
特种医学 | 88871篇 |
外国民族医学 | 490篇 |
外科学 | 357973篇 |
综合类 | 47720篇 |
现状与发展 | 12篇 |
一般理论 | 871篇 |
预防医学 | 185013篇 |
眼科学 | 54656篇 |
药学 | 176693篇 |
11篇 | |
中国医学 | 4633篇 |
肿瘤学 | 131030篇 |
出版年
2021年 | 19412篇 |
2019年 | 20267篇 |
2018年 | 27873篇 |
2017年 | 21054篇 |
2016年 | 23423篇 |
2015年 | 26500篇 |
2014年 | 37135篇 |
2013年 | 55430篇 |
2012年 | 76332篇 |
2011年 | 81299篇 |
2010年 | 48276篇 |
2009年 | 45697篇 |
2008年 | 76293篇 |
2007年 | 81166篇 |
2006年 | 81939篇 |
2005年 | 79498篇 |
2004年 | 76020篇 |
2003年 | 73374篇 |
2002年 | 71073篇 |
2001年 | 109002篇 |
2000年 | 111665篇 |
1999年 | 93783篇 |
1998年 | 27330篇 |
1997年 | 23974篇 |
1996年 | 24314篇 |
1995年 | 23001篇 |
1994年 | 21133篇 |
1993年 | 19934篇 |
1992年 | 72156篇 |
1991年 | 70242篇 |
1990年 | 68526篇 |
1989年 | 65784篇 |
1988年 | 60430篇 |
1987年 | 59255篇 |
1986年 | 55335篇 |
1985年 | 53127篇 |
1984年 | 39432篇 |
1983年 | 33500篇 |
1982年 | 20005篇 |
1979年 | 35949篇 |
1978年 | 25740篇 |
1977年 | 21308篇 |
1976年 | 20398篇 |
1975年 | 21867篇 |
1974年 | 26189篇 |
1973年 | 24851篇 |
1972年 | 23259篇 |
1971年 | 22081篇 |
1970年 | 20283篇 |
1969年 | 19350篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
L. TIMMER-DE MIK M.D. D.M. BROEKHUIJSEN-VAN HENTEN M.D. † J.M. OLDHOFF M.D. PH.D. D.B. DE GEER M.D. ‡ V. SIGURDSSON M.D. PH.D. S.G.M.A. PASMANS M.D. PH.D. 《Pediatric dermatology》2009,26(3):358-360
Abstract: In Sweet's syndrome, the essential features are the characteristic morphology of the lesions, their histologic appearance, the dramatic response to corticosteroids and the absence of scarring. We report an 8-month-old infant in whom Sweet's syndrome was diagnosed and who developed acquired cutis laxa in the skin lesions. 相似文献
992.
A. Perez S. E. Clements E. Benton A. Robson B. Bhogal C. M. Stefanato D. McGibbon 《Clinical and experimental dermatology》2009,34(8):e931-e933
We report a case of localized bullous pemphigoid (BP) in a woman patient with primary lymphoedema tarda. There is only one previous case reported of localized pemphigoid in an area of lymphoedema, this being of the cicatricial variant. Slow circulation in the lymphatic vessels, increased capillary permeability with preferential localization of antibodies in the area, and potential cleavage of the epidermal junction due to increased hydrostatic pressure leading to autoimmunity, have all been advocated as possible pathogenic mechanisms. Nevertheless, we consider that the mechanism by which localized pemphigoid arises on lymphoedema remains elusive, based on a previous case of generalized BP sparing an area of postsurgical lymphoedema. 相似文献
993.
M. Laurin Council Jennifer M. Gardner Cynthia Helms Ying Liu Lynn A. Cornelius Anne M. Bowcock 《Experimental dermatology》2009,18(5):485-487
Abstract: The risks of developing malignant melanoma (MM) include ultraviolet irradiation and genetic factors. To examine the contribution of rare and common variation within known MM genes in sporadic US MM patients, coding regions of known MM susceptibility genes [cyclin-dependent kinase inhibitor 2A ( CDKN2A ), cyclin-dependent kinase 4, melanocortin 1 receptor ( MC1R ) and tyrosinase ( TYR )] were resequenced in 109–135 MM cases. The significance of variants was examined by comparing their frequencies in 390 cancer-free controls. Potential deleterious mutations in CDKN2A were found in two patients and two others had variants of unknown significance. Cases were more likely than controls to harbour the MC1R 'R' variants known or predicted to alter its function ( P = 0.002), particularly the R160W variant ( P = 0.0035). The associated TYR R402Q variant (rs1126809*A) was found in 29% of cases, similar to what has been described previously. One MM patient with a family history of MM, who had developed other skin cancers, was homozygous for a novel TYR variant (P406L) of unknown significance. Hence, rare variants in TYR may be important risk factors for skin cancer. 相似文献
994.
Psoriasis is a chronic inflammatory condition that often requires life-long treatment. Conventional therapies have not fully met the needs of psoriatic patients, because of limited efficacy, adverse effects with cumulative use, and patient inconvenience. In the past decade, biologic immunotherapies have become accepted treatments for psoriasis as a result of perceived efficacy and safety on the part of patients and practitioners. However, most data on these medications come from relatively limited short-term trials. In this review, we will focus on the available long-term data on the efficacy of the biologic agents. We will emphasize the strengths and weakness of the available data of the biologic agents that are Food and Drug Administration (FDA)-approved for the treatment of moderate to severe psoriasis (alefacept, efalizumab, * etanercept, infliximab, and adalimumab), with the inclusion of a newer agent currently under FDA evaluation (ustekinumab). 相似文献
995.
R. San Juan M. Yebra C. Lumbreras F. López-Medrano M. Lizasoain J.C. Meneu J. Delgado A. Andrés J.M. Aguado 《Clinical transplantation》2009,23(5):666-671
Abstract: Long-term prophylaxis against cytomegalovirus (CMV) started immediately after transplantation in (D+/R−) poses a higher risk of late-onset CMV disease. Delayed CMV prophylaxis could allow a transitory exposure of the immune system to CMV, which would let the immune system mount an adequate CMV-specific cytotoxic response in (D+/R−) patients and confer protection against CMV disease. We included all (D+/R−) solid organ transplant recipients (SOT) performed at our institution (January 3/October 6) who received CMV prophylaxis (mainly with oral valganciclovir) during 100 d. In the first period (until December 4), prophylaxis was initiated immediately after transplantation (conventional prophylaxis: CP). Since January 5, it was initiated after 14 d (delayed prophylaxis: DP). Incidence and severity of CMV disease was compared between both groups. A total of 44 SOT recipients were included (CP: 26 and DP: 18). CMV disease was diagnosed in eight patients (18%), seven of 26 (27%) in the CP group, and one of 18 (5.5%) in the DP group (p = 0.07). CMV colitis was reported in five of 26 patients in the CP group (19%), whereas there were no cases of visceral CMV disease in the DP group (p = 0.048). A 14-d delay in the beginning of long-term prophylaxis against CMV in (D+/R−) is safe and could prevent the onset of late-CMV disease. 相似文献
996.
Beta2-Microglobulin 总被引:1,自引:0,他引:1
Among the uremic toxins in the "middle molecule" range, beta2-microglobulin (β2-M) is certainly one of the most frequently studied compounds. Its serum level increases with the progression of chronic kidney disease, to reach very high concentrations in patients with end-stage kidney disease. It is the major protein component of dialysis-related amyloidosis, a dramatic complication which results from high extracellular concentration and posttranslational modification of β2-M and a number of other promoters of amyloid fibril formation and deposition in osteo-articular tissues. Effective removal of β2-M can be achieved with highly effective hemodialysis and hemodiafiltration techniques but predialysis session serum levels cannot be normalized. The prevalence and severity of β2-M amyloidosis appear to have decreased in the last 20 years, although its occurrence may simply be delayed. 相似文献
997.
998.
Seok L Ong Gianpiero Gravante Cristina A Pollard M'Balu A Webb Severine Illouz Ashley R Dennison 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2009,11(8):613-621
Pain control is one of the most challenging aspects in the management of chronic pancreatitis. Total pancreatectomy can successfully relieve the intractable abdominal pain in these patients but will inevitably result in insulin-dependent diabetes. Islet autotransplantation aims to preserve, as far as possible, the insulin secretory function of the islet cell mass thereby reducing (or even removing) the requirement for exogenous insulin administration after a total pancreactomy. Despite the relatively small number of centres able to perform these procedures, there are important technical variations in the details of their approaches. The aim of this review is to provide details of the current surgical practice for total pancreatectomy combined with islet autotransplantation, and outline the potential advantages and disadvantages of the variations adopted in each centre. 相似文献
999.
1000.